“Because of the aging population, orthopaedic surgeons will be increasingly confronted with the problem of cup loosening in older patients”, explained Dr. Wolf-Dietrich Hübner, Director of the Medical Division at curasan AG, before adding: “This will inevitably lead to an increase in the number of revision procedures required.”
Cerasorb M (ß-tricalcium phosphate) was used in over 30 operations by the orthopaedic surgeons. In 13 of these cases mixed with autogenous bone and subsequent observation period was minimum 2 years. Of all 27 cases results were satisfactory, even though four patients received replacement under septic conditions. “These results are clearly attributable in large measure to Cerasorb M’s phase purity of over 99%”, stated Dr. Hübner, before continuing: “Furthermore, there is no potential for disease transmission with Cerasorb M, in contrast to established products made from human or bovine bone material.”
Cerasorb M used for the filling of defects during hip endoprosthesis replacement procedures leads to outstanding bone consolidation. The newly formed autogenous bone creates a good basis for any other potential subsequent procedures that may be necessary. In case of older patients, Cerasorb M can be used either in combination with bone or alone. Cerasorb M regardless of the patients’ age has been demonstrated to be a good alternative to classic bone cement for the filling of defects during endoprostheses revisions.
